Author

A. Chandrabalan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1

Frequent Co-Authors

R. Ramachandran· 2 shared A. Firth· 1 shared A. Getgood· 1 shared C. T. Appleton· 1 shared R. B. Litchfield· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

R. Ramachandran

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Autocrine Proteinase Activated Receptor (PAR) mediated signaling in prostate cancer cells.

A. Chandrabalan, R. Ramachandran

This study identifies autocrine PAR signaling as a regulator of prostate cancer cell function through proteolytic enzyme-mediated cleavage and differential gene regulation.

bioRxiv · Aug 22, 2022 · PreprintCancer Biology

Identification of Proteinase Activated Receptor (PAR) cleaving enzymes in human osteoarthritis knee joint synovial fluids.

A. Chandrabalan, A. Firth, R. B. Litchfield, C. T. Appleton, A. Getgood, R. Ramachandran

This study identifies serine proteinases and matrix metalloproteinases as major PAR activating enzymes in OA synovial fluids, suggesting potential therapeutic targets for OA.

bioRxiv · Oct 21, 2020 · PreprintPharmacology & Toxicology